The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0606-2022·Announced 2022-03-02

DG Health Nasal Spray Recalled for Contaminated Excipient

Perrigo Company PLC is recalling DG Health Nasal Spray (Oxymetazoline HCl 0.05%) distributed nationwide because the product was manufactured with a contaminated excipient that was itself recalled from the supplier.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall involving a cGMP deviation—use of a contaminated excipient. The source text does not report any illnesses, injuries, or deaths, and the hazard is a manufacturing compliance issue rather than a known pathogen or established safety threat. This fits the Moderate category for a Class II precautionary recall.

Plain-English summary

Perrigo Company PLC is recalling DG Health Nasal Severe Congestion No Drip Nasal Spray Plus Menthol (Oxymetazoline HCl 0.05%, 1 FL Oz / 30 mL bottles, NDC 55910-511-10) distributed nationwide in the United States. The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled by the excipient supplier.

Affected batches include: 1BK0716 (Exp 12/31/2022), 1CK0899 (Exp 01/31/2023), and 1FK1163 (Exp 01/31/2023).

The recalled product was distributed by Dolgencorp, LLC, located at 100 Mission Ridge, Goodlettsville, TN 37072. Consumers who have purchased this product should stop using it and consult with a healthcare provider if they have questions or concerns about their use of the recalled product.

The recalled product

Product
DG HEALTH NASAL (OXYMETAZOLINE HYDROCHLORIDE)
Brand
DG HEALTH NASAL
Manufacturer
Perrigo Company PLC
Category
Drug — Over-the-Counter Nasal Decongestant
Hazard
Affected units
214,824

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Batch: 1BK0716
  • Exp 12/31/2022)
  • 1CK0899
  • Exp 01/31/2023
  • 1FK1163

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 51 products in this recall →

Related recalls

Same brand · DG HEALTH NASAL

Same manufacturer · Perrigo Company PLC

See all →

Same hazard · cgmp deviation

See all →

Similar recalls